New horizons in diabetic neuropathies: an updated review on their pathology, diagnosis, mechanism, screening techniques, pharmacological, and future approaches
J Neurochem 44(2):411420 Stewart MH, Lavie CJ, Ventura HO (2018) Future pharmacological therapy in hypertension
Moreover, the observed high incidence of MACEs, which reached 12.0% in the non-users during follow-up, highlights the elevated cardiovascular risk among KTRs with T2DM, underscoring the importance of incorporating GLP-1 RAs into the DM care for these specific population
This includes nicotinamide riboside kinases, nicotinamide phosphoribosyltransferase, and other methyltransferases that could confound experimental results